INHIBITION OF TERMINAL AXONAL SPROUTING BY SERUM FROM PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
INHIBITION OF TERMINAL AXONAL SPROUTING BY SERUM FROM PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
复制标题
DOI:
10.1056/nejm198410113111501
复制
发表时间:
1984-01-01
影响因子:
158.5
通讯作者:
ANTEL, JP
中科院分区:
文献类型:
--
作者:
GURNEY, ME;BELTON, AC;ANTEL, JP
To investigate the pathogenesis of amyotrophic lateral sclerosis, the effect of serum from patients with this disease on the regenerative sprouting of terminal axons in botulinum-treated mouse gluteus muscle was compared with the effects of serum from controls and from patients with diabetic peripheral neuropathy. Serum from 9 of 19 patients with the sporadic form of amyotrophic lateral sclerosis and from 2 of 6 patients with the familial form caused a reduction in the proportion of sprouting terminal axons, as compared with that found in muscles treated with serum from controls or diabetic patients. Ig from patients with amyotrophic lateral sclerosis, when tested on immunoblots, recognized a 56-kilodalton protein secreted by denervated rat diaphragm muscle; rabbit antiserum raised against this protein also suppressed terminal axonal sprouting. An antibody in the patients'' serum with amyotrophic lateral sclerosis that inhibits neuron sprouting and subsequent skeletal muscle reinnervation was detected. Whether this antibody is of primary pathogenic importance or represents a secondary response to neuromuscular destruction is not known. Serum from patients with amyotrophic lateral sclerosis may provide reagents for trophic communication studies between muscle and motor neurons.